abstract of the disclosure in certain embodiments multi-component formulations are provided where the formulations comprising a first component comprising one or more vitamins selected from the group consisting of one or more b vitamins, vitamin c, vitamin d, vitamin e, co-enzyme q10 vitamin K and folate; a second component comprising one or more elements selected from the group consisting of selenium, lithium, magnesium, and molybdenum; a third component comprising one or more omega-3 fatty acids; and a fourth component comprising one or more amino acids selected from the group consisting of trimethylglycine, n-acetyl cysteine, s-adenosyl methionine, l-tryptophan, and glutathione. Abstract of the Patent Summary: "Multiple Component Formulation to Enhance Neurological Function". The present invention relates, in certain embodiments, to multi-component formulations provided, wherein the formulations comprise a first component comprising one or more vitamins selected from the group consisting of one or more vitamins b, vitamin c, vitamin d, vitamin e, coenzyme q10, vitamin ke folate; a second component comprising one or more elements selected from the group consisting of selenium, lithium, magnesium and molybdenum; a third component comprising one or more omega-3 fatty acids; and a fourth component comprising one or more amino acids selected from the group consisting of trimethylglycine, n-acetyl cysteine, s-adenosyl methionine, 1-tryptophan and glutathione. 1/1abstract of the disclosure in certain embodiments multi-component formulations are provided where the formulations comprise a first component comprising one or more vitamins selected from the group consisting of one or more b vitamins, vitamin c, vitamin d, vitamin e, co-enzyme q10, vitamin k, and folate; a second component comprising one or more elements selected from the group consisting of selenium, lithium, magnesium, and molybdenum; a third component comprising one or more omega-3 fatty acids; and a fourth